173 related articles for article (PubMed ID: 20368992)
1. Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.
Jensen CJ; Stankovich J; Van der Walt A; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Johnson LJ; Wilkins E; Field J; Danoy P; Brown MA; ; Rubio JP; Butzkueven H
PLoS One; 2010 Apr; 5(4):e10003. PubMed ID: 20368992
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.
Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)
Nat Genet; 2009 Jul; 41(7):824-8. PubMed ID: 19525955
[TBL] [Abstract][Full Text] [Related]
3. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
[TBL] [Abstract][Full Text] [Related]
4. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
[TBL] [Abstract][Full Text] [Related]
5. Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.
Schmied MC; Zehetmayer S; Reindl M; Ehling R; Bajer-Kornek B; Leutmezer F; Zebenholzer K; Hotzy C; Lichtner P; Meitinger T; Wichmann HE; Illig T; Gieger C; Huber K; Khalil M; Fuchs S; Schmidt H; Auff E; Kristoferitsch W; Fazekas F; Berger T; Vass K; Zimprich A
Neurogenetics; 2012 May; 13(2):181-7. PubMed ID: 22411505
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
7. GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians.
Bashinskaya VV; Kulakova OG; Kiselev IS; Baulina NM; Favorov AV; Boyko AN; Tsareva EY; Favorova OO
J Neuroimmunol; 2015 May; 282():85-91. PubMed ID: 25903733
[TBL] [Abstract][Full Text] [Related]
8. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
10. A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis.
Xia Z; Chibnik LB; Glanz BI; Liguori M; Shulman JM; Tran D; Khoury SJ; Chitnis T; Holyoak T; Weiner HL; Guttmann CR; De Jager PL
PLoS One; 2010 Nov; 5(11):e14169. PubMed ID: 21152065
[TBL] [Abstract][Full Text] [Related]
11. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.
Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M
Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147
[TBL] [Abstract][Full Text] [Related]
12. The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.
Qiu W; Pham K; James I; Nolan D; Castley A; Christiansen FT; Czarniak P; Luo Y; Wu J; Garlepp M; Wilton S; Carroll WM; Mastaglia FL; Kermode AG
J Neuroimmunol; 2013 Aug; 261(1-2):92-7. PubMed ID: 23726763
[TBL] [Abstract][Full Text] [Related]
13. Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Simon KC; Munger KL; Kraft P; Hunter DJ; De Jager PL; Ascherio A
J Neurol; 2011 Sep; 258(9):1676-82. PubMed ID: 21431378
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.
Isobe N; Keshavan A; Gourraud PA; Zhu AH; Datta E; Schlaeger R; Caillier SJ; Santaniello A; Lizée A; Himmelstein DS; Baranzini SE; Hollenbach J; Cree BA; Hauser SL; Oksenberg JR; Henry RG
JAMA Neurol; 2016 Jul; 73(7):795-802. PubMed ID: 27244296
[TBL] [Abstract][Full Text] [Related]
15. Association of Multiple Sclerosis Phenotypes with Single Nucleotide Polymorphisms of
Al-Eitan L; Qudah MA; Qawasmeh MA
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111053
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
17. Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA.
Matiello M; Weinshenker BG; Atkinson EJ; Schaefer-Klein J; Kantarci OH
Mult Scler; 2011 May; 17(5):634-6. PubMed ID: 21239413
[TBL] [Abstract][Full Text] [Related]
18. Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis.
Alcina A; Fernández O; Gonzalez JR; Catalá-Rabasa A; Fedetz M; Ndagire D; Leyva L; Guerrero M; Arnal C; Delgado C; Lucas M; Izquierdo G; Matesanz F
Eur J Hum Genet; 2010 Jul; 18(7):827-31. PubMed ID: 20087403
[TBL] [Abstract][Full Text] [Related]
19. Variants of ST8SIA1 are associated with risk of developing multiple sclerosis.
Husain S; Yildirim-Toruner C; Rubio JP; Field J; ; Schwalb M; Cook S; Devoto M; Vitale E
PLoS One; 2008 Jul; 3(7):e2653. PubMed ID: 18612409
[TBL] [Abstract][Full Text] [Related]
20. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
